PCHEM’s 2019 results were below our and the street’s forecast by 13- 15%, dragged down by a weaker F&M segment and weak margins at the O&D segment. More details will be shared in the results conference call on 27 February (3pm) as to whether there are any one-offs that resulted in the higher operating costs (+36% qoq) dragging down the EBITDA margin (-13ppts qoq). In line with the weak results, no special dividend was declared by PCHEM. YTD payout totalled 18sen, 43% lower compared to 32sen in 2018. We upgrade our rating to Hold from Sell on valuation but at lower target price of RM6.00.
PCHEM reported 4Q headline profit of RM340m (-39% qoq, -74% yoy). After stripping out the non-core items (inventory write-backs), core profit fell to RM278m (-55% qoq, -79% yoy). While full-year plant utilisation was relatively flat at low 90%, 2019 core profit fell 45% yoy, impacted by lower product ASP, margin compression (particularly in 4Q19) and losses at the associate level dragged by its Aroma plant with low plant utilisation.
We trim our 2020-21E EPS by 6-10% as we expect a potential slowdown in the economic environment to affect PCHEM demand. We lower our target price to RM6.00 (from RM6.40), pegged to an unchanged 16x PER (the historical average), but upgrade the stock to a Hold on valuation grounds. Risks to our call include: fluctuations in product ASP and better- /less-than-expected global demand.
Source: Affin Hwang Research - 27 Feb 2020
Chart | Stock Name | Last | Change | Volume |
---|
2024-07-12
PCHEM2024-07-12
PCHEM2024-07-12
PCHEM2024-07-12
PCHEM2024-07-11
PCHEM2024-07-11
PCHEM2024-07-11
PCHEM2024-07-11
PCHEM2024-07-10
PCHEM2024-07-10
PCHEM2024-07-10
PCHEM2024-07-10
PCHEM2024-07-09
PCHEM2024-07-09
PCHEM2024-07-09
PCHEM2024-07-09
PCHEM2024-07-05
PCHEM2024-07-05
PCHEMCreated by kltrader | Jan 03, 2023
Created by kltrader | Sep 30, 2022